Vor Bio to Participate in Stifel 2024 Healthcare Conference

Equillium to Present at the Stifel Healthcare Conference
Equillium, Inc. (Nasdaq: EQ), a clinical-stage biotechnology company leveraging a deep understanding of immunobiology to develop novel therapeutics to treat severe autoimmune and inflammatory disorders,
Compass Pathways To Participate In Stifel 2024 Healthcare Conference
( MENAFN - GlobeNewsWire - Nasdaq) LONDON, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that management will present at the Stifel 2024 Healthcare conference at 10:55 am ET on November 19, 2024.
Krystal Biotech to Present at Stifel 2024 Healthcare Conference
A webcast of the presentation will be available here beginning at 10:55 am ET on Monday, November 18, 2024 and will be posted on the Investors section of the Company’s website. About Krystal Biotech,
Vistagen to Present at the Stifel 2024 Healthcare Conference
Vistagen (Nasdaq: VTGN), a late clinical-stage company dedicated to pioneering neuroscience based on nose-to-brain neurocircuitry, today announced that company management will present and host one-on-one meetings during the Stifel 2024 Healthcare Conference taking place November 18 and 19,
Fulcrum Therapeutics to Participate in the Stifel Healthcare Conference
The webcast of the fireside chat will be accessible here and by visiting the "Events and Presentations" section of Fulcrum Therapeutics’ website at https://ir.fulcrumtx.com/events-and-presentations. A replay of the webcast will be available on Fulcrum Therapeutics’ website for at least 30 days following the presentation.
Geron to Participate in the Stifel 2024 Healthcare Conference
Geron Corporation (Nasdaq: GERN), a commercial-stage biopharmaceutical company, today announced members of the management team are scheduled to partic
X4 Pharmaceuticals to Participate in the Stifel 2024 Healthcare Conference
BOSTON, Nov. 14, 2024 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals (Nasdaq: XFOR), a company driven to improve the lives of people with rare diseases of the immune system, today announced that management will participate in the Stifel 2024 Healthcare Conference, taking place in New York, NY on November 18-19, 2024.
Baxter to Present at Stifel 2024 Healthcare Conference
Baxter International Inc. (NYSE:BAX), a global medtech leader, will present at the Stifel 2024 Healthcare Conference on Monday, November 18, 2024. Joel Grade, Baxter's chief financial officer, is scheduled to present at 8:35 a.m. Eastern Time.
Pliant Therapeutics to Participate in the Stifel Healthcare Conference
Pliant Therapeutics, Inc. (Nasdaq: PLRX), today announced that Keith Cummings, M.D., Chief Financial Officer, and Greg Cosgrove, M.D. FCCP, will participate in a fireside chat at the Stifel 2024 Healthcare Conference on Tuesday,
Vor Bio to Participate in the Stifel 2024 Healthcare Conference
Monday, November 18, 2024 at 2:25 pm ET Location: New York, NY A live webcast and archived replay of the fireside chat will be available on the investors section of About Vor Bio Vor Bio is a clinical-stage cell and genome engineering company that aims to change the standard of care for patients with blood cancers by engineering hematopoietic stem cells to enable targeted therapies post-transplant.
Yahoo Finance1d
Atara Biotherapeutics to Participate at the Stifel 2024 Healthcare Conference
will participate in a fireside chat at the Stifel 2024 Healthcare Conference on Monday, November 18, 2024 at 6:10 a.m.
Morningstar13d
Evolus to Participate in Stifel 2024 Healthcare Conference
today announced that members of its management team will present at the Stifel Healthcare Conference in New York City on Tuesday, November 19 at 10:55 AM ET. The presentation can be accessed on ...